idarubicin has been researched along with Carcinoma, Transitional Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burk, K; Mross, K; Schultze-Seemann, W; Sommerkamp, H | 1 |
1 trial(s) available for idarubicin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Intravesical idarubicin--a phase-I study.
Topics: Administration, Intravesical; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Female; Humans; Idarubicin; Male; Middle Aged; Tissue Distribution; Urinary Bladder Neoplasms | 1994 |